Download PDF
Zeitschrift für Orthomolekulare Medizin 2016; 14(04): 5-15
DOI: 10.1055/s-0042-122819
Wissen
Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart – New York

Entgiftung: Effektiv bei vielen Krankheiten

Joachim Mutter
Further Information

Publication History

Publication Date:
14 July 2017 (online)

    Permissions and Reprints

Summary

Natürliche und auch künstliche Chemikalien können den Organismus schwächen und krank machen. Für viele Menschen, besonders bei bestehenden Krankheiten oder Beschwerden, kann eine regelmäßige Entgiftung sinnvoll sein. Gegen Metalle, Halbmetalle und manche radioaktive Isotope sind spezifische Gegenmittel (Antidote) verfügbar. Bei anderen Giftstoffen gibt es, außer bei einigen in der Akuttoxikologie (wie z. B. Antiseren gegenüber Schlangengiften, Atropin gegen Cholinesterasehemmstoffen) keine spezifischen Gegenmittel.

Der Autor gibt einen Überblick über die wichtigsten Entgiftungsstrategien bei chronischen Beschwerden sowie praktische Hinweise.

Keywords

Entgiftung - Schwermetallbelastung - chronische Krankheiten
 

  • Literatur

  • 1 Adams JB, Baral M, Geis E. et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol 2009; 9: 17
    CrossrefGoogle Scholar
  • 2 Alexandrov PN, Kruck TP, Lukiw WJ. Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein (CRP) in human brain microvessel endothelial cells (hBMECs). J Inorg Biochem 2015; 152: 210-213
    CrossrefGoogle Scholar
  • 3 Bartova J, Prochazkova J, Kratka Z. et al. Dental amalgam as one of the risk factors in autoimmune diseases. Neuroendocrinol Lett 2003; 24: 65-67
    Google Scholar
  • 4 Bernard S, Enayati A, Roger H. et al. The role of mercury in the pathogenesis of autism. Mol Psychiatry 2002; 7 Suppl 2 S42-S43
    CrossrefGoogle Scholar
  • 5 BMBF 1995 Forschungserfolg: Erstmals Hinweise über Entstehung von Autoimmunkrankheiten. Forschungsinfo 7.8.1995, Nr 24/25. Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (BMBF);
    Google Scholar
  • 6 Böse-O'Reilly S, Drasch G, Beinhoff C. et al. The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval). Sci Total Environ 2003; 307 1–3 71-82
    CrossrefGoogle Scholar
  • 7 Clarke D, Buchanan R, Gupta N. et al. Amelioration of Acute Mercury Toxicity by a Novel, Non-Toxic Lipid Soluble Chelator N,N‘bis-(2-mercaptoethyl)isophthalamide: Effect on Animal Survival, Health, Mercury Excretion and Organ Accumulation. Toxicol Environ Chem 2012; 94 (03) 616-640
    CrossrefGoogle Scholar
  • 8 Crapper McLachlan DR, Dalton AJ, Kruck TP. et al. Intramuscular desferrioxamine in patients with Alzheimer‘s disease. Lancet 1991; 337 8753 1304-1308
    CrossrefGoogle Scholar
  • 9 Daschner F, Mutter J. Sondervotum zu „Amalgam: Stellungnahme aus umweltmedizinischer Sicht“, Mitteilung der Kommission „Methoden und Qualitätssicherung in der Umweltmedizin“ des Robert-Koch-Institutes, Berlin. Bundesgesundheitsbl- Gesundheitsforsch- Gesundheitsschutz 2007; 50: 1432-1433
    Google Scholar
  • 10 Dorea JG. Exposure to mercury and aluminum in early life: developmental vulnerability as a modifying factor in neurologic and immunologic effects. Int J Environ Res Public Health 2015; 12 (02) 1295-1313
    CrossrefGoogle Scholar
  • 11 Drasch G, Bose-O'Reilly S, Beinhoff C. et al. The Mt. Diwata study on the Philippines 1999--assessing mercury intoxication of the population by small scale gold mining. Sci Total Environ 2001; 267: 151-168
    CrossrefGoogle Scholar
  • 12 Drasch G, Bose-O'Reilly S, Maydl S. et al. Scientific comment on the German human biological monitoring values (HBM values) for mercury. Int J Hyg Environ Health 2002; 205: 509-512
    CrossrefGoogle Scholar
  • 13 Drasch G, Mail der S, Schlosser C. et al. Content of non-mercury-associated selenium in human tissues. Biol Trace Elem Res 2000; 77: 219-230
    CrossrefGoogle Scholar
  • 14 Drasch G, Wanghofer E, Roider G. Are blood, urine, hair, and muscle valid bio-monitoring parameters for the internal burden of men with the heavy metals mercury, lead and cadmium?. Trace Elem Electrolytes 1997; 14: 116-123
    Google Scholar
  • 15 Drevnick PE, Lamborg CH, Horgan MJ. Increase in mercury in Pacific yellowfin tuna. Environ Toxicol Chem 2015; 34 (04) 931-934
    CrossrefGoogle Scholar
  • 16 Duhr EF, Pendergrass JC, Slevin JT. et al. HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin. Toxicol Appl Pharmacol 1993; 122: 273-280
    CrossrefGoogle Scholar
  • 17 Ericson JE, Shirahata H, Patterson CC. Skeletal concentrations of lead in ancient Peruvians. N Engl J Med 1979; 300 (17) 946-951
    CrossrefGoogle Scholar
  • 18 Ferrero ME. Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic Metals. Biomed Res Int 2016; 2016: 8274504
    Google Scholar
  • 19 Frustaci A, Magnavita N, Chimenti C. et al. Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. J Am Coll Cardiol 1999; 33 (06) 1578-1583
    CrossrefGoogle Scholar
  • 20 Hahn LJ, Kloiber R, Leininger RW. et al. Whole-body imaging of the distribution of mercury released from dental fillings into monkey tissues. FASEB J 1990; 4: 3256-3260
    CrossrefGoogle Scholar
  • 21 Hahn LJ, Kloiber R, Vimy MJ. et al. Dental „silver“ tooth fillings: a source of mercury exposure revealed by whole-body image scan and tissue analysis. FASEB J 1989; 3: 2641-2646
    CrossrefGoogle Scholar
  • 22 Haley BE. Mercury toxicity: Genetic susceptibility and synergistic effects. Medical Veritas 2005; 2: 535-542 www.1796kotok.com/pdfs/haley.pdf
    CrossrefGoogle Scholar
  • 23 Haley Boyd. Universität Kentucky; Vortrag 12.6.2010 München: Slide 9 http://www.draloisdengg.at/bilder/pdf/BoydHaleyToxicity_Oral_Infection_Amalgam.pdf
  • 24 Harris HH, Vogt S, Eastgate H. et al. Migration of mercury from dental amalgam through human teeth. J Synchrotron Radiat 2008; 15 Pt 2 123-128
    CrossrefGoogle Scholar
  • 25 Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 2003; 22: 277-285
    CrossrefGoogle Scholar
  • 26 Hultman P, Johansson U, Turley SJ. et al. Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. FASEB J 1994; 8: 1183-1190
    CrossrefGoogle Scholar
  • 27 Kennedy R. Thimerosal and autism: Lets the science speak. Skyhorse Publishing; 2014
    Google Scholar
  • 28 Kim YN, Kim YA, Yang AR. et al. Relationship between Blood Mercury Level and Risk of Cardiovascular Diseases: Results from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV) 2008-2009. Prev Nutr Food Sci 2014; 19 (04) 333-342
    Google Scholar
  • 29 Klinghardt D. Schwermetalle und ihre Wirkungen auf die Gesundheit. Vortrag auf Schloß Elmau; 1996. www.rohkostwiki.de/wiki/Vortrag_von_Dr._med._Dietrich_Klinghardt_%C3%BCber_Schwermetalle
    Google Scholar
  • 30 Leitzmann C, Mutter J. Vitamin B12 Kontroverse. Wurzel 2014; 1: 38-44 http://www.detoxklinik.de/files/9813/9927/9204/B12_Kontroverse_comp.pdf
    Google Scholar
  • 31 Leong CC, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 2001; 12: 733-737
    CrossrefGoogle Scholar
  • 32 Lettmeier B, Böse o Reilly S, Drasch G. Proposal for a revised reference concentration (RfC) for mercury vapour in adults. Sci Total Environ 2010; 408 (17) 3530-3535
    CrossrefGoogle Scholar
  • 33 Lorscheider FL, Vimy MJ, Summers AO. Mercury exposure from „silver“ tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J 1995; 9: 504-508
    CrossrefGoogle Scholar
  • 34 Mangelsdorf I. Healing Motorneurondiseas – a case report [Master Thesis]. Europa Universität Frankfurt (Oder): 2016
  • 35 Menke A, Muntner P, Batuman V. et al. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 2006; 114 (13) 1388-1394
    CrossrefGoogle Scholar
  • 36 Mutter J, Naumann J, Walach H. et al. Amalgam: Eine Risikobewertung unter Berücksichtigung der neuen Literatur bis 2005. Gesundheitswesen 2005a 67: 204-216
    Article in Thieme ConnectGoogle Scholar
  • 37 Mutter J, Naumann J, Walach H. et al. Mercury and autism: Accelerating Evidence?. Neuroendocrin Lett 2005b 26: 439-446
    Google Scholar
  • 38 Mutter J. Is Dental Amalgam Safe for Humans?. The European Commission‘s SCENIHR Opinion. J Occup Med Toxicol 2011; 6: 2
    Google Scholar
  • 39 Mutter J. Amalgam-Risiko für die Menschheit. Weil der Stadt; Natura viva: 2000
    Google Scholar
  • 40 Mutter J. Gesund statt chronisch krank. Weil der Stadt; Natura viva: 2009
    Google Scholar
  • 41 Mutter J. Lass Dich nicht vergiften. München: Gräfe & Unzer; 2012
    Google Scholar
  • 42 National Institute of Health 2015: Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication (NBMI) https://clinicaltrials.gov/ct2/show/NCT02486289
  • 43 Omura Y, Beckman SL. Role of mercury (Hg) in resistant infections & effective treatment of Chlamydia trachomatis and Herpes family viral infections (and potential treatment for cancer) by removing localized Hg deposits with Chinese parsley and delivering effective antibiotics using various drug uptake enhancement methods. Acupunct Electrother Res 1995; 20 3–4 195-229
    CrossrefGoogle Scholar
  • 44 Opitz H, Schweinsberg F, Grossmann T. et al. Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure. Clin Neuropathol 1996; 15: 139-144
    Google Scholar
  • 45 Panahi Y, Darvishi B, Jowzi N. et al. Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties. Curr Pharm Des 2016; 22 (02) 164-173
    Google Scholar
  • 46 Patterson C, Ericson J, Manea-Krichten M. et al. Natural skeletal levels of lead in Homo sapiens sapiens uncontaminated by technological lead. Sci Total Environ 1991; 107: 205-236
    CrossrefGoogle Scholar
  • 47 Percy ME, Kruck TP, Pogue AI. et al. Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer‘s disease. J Inorg Biochem 2011; 105 (11) 1505-1512
    CrossrefGoogle Scholar
  • 48 Rogan WJ, Ware JH. Exposure to lead in children – how low is low enough?. N Engl J Med 2003; 348: 1515-1516
    CrossrefGoogle Scholar
  • 49 Rooney JP. The retention time of inorganic mercury in the brain – a systematic review of the evidence. Toxicol Appl Pharmacol 2014; 274 (03) 425-435
    CrossrefGoogle Scholar
  • 50 Ruprecht J. Dimaval (DMPS)/ DMPS-Heyl- wissenschaftliche Produktmonographie. 6. Aufl. 2010
  • 51 Schubert J, Riley EJ, Tyler SA.  . Combined effects in toxicology – a rapid systematic testing procedure: cadmium, mercury, and lead. J Toxicol Environ Health 1978; 4: 763-776
    Google Scholar
  • 52 Singh A1, Singh SP, Bamezai R. Inhibitory potential of Chlorella vulgaris (E-25) on mouse skin papillomagenesis and xenobiotic detoxication system. Anticancer Res 1999; 19 (3A): 1887–1891
  • 53 Somers EC, Ganser MA, Warren JS. et al. Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES. Environ Health Perspect 2015; 123 (08) 792-798
    Google Scholar
  • 54 Stejskal J, Stejskal VD. The role of metals in autoimmunity and the link to neuroendocrinology. Neuroendocrinol Lett 1999; 20: 351-364
    Google Scholar
  • 55 Thier R, Bonacker D, Stoiber T. et al. Interaction of metal salts with cytoskeletal motor protein systems. Toxicol Lett 2003; 140–141: 75-81
    Google Scholar
  • 56 Uchikawa T, Kumamoto Y, Maruyama I. et al. Enhanced elimination of tissue methylmercury in Parachlorella beijerinckii-fed mice. J Toxicol Sci 2011; 36 (01) 121-126
    CrossrefGoogle Scholar
  • 57 UNEP (United Nations Environment Programm) (Chemicals): Global Mercury Assesment. UNEP Chemicals Geneva; Dezember 2002
    Google Scholar
  • 58 Virtanen JK, Voutilainen S, Rissanen TH. et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 2005; 25 (01) 228-233
    Google Scholar
  • 59 Walach H, Mutter J, Deth R. Inorganic Mercury and Alzheimer‘s Disease – Results of a Review and a Molecular Mechanism. In: Martin CR, Preedy VR, eds. Diet and Nutrition in Dementia and Cognitive Decline London: Academic Press, Elsevier; 2014: 593-601
    Google Scholar
  • 60 WHO, ed. Environmental Health Criteria 118: Inorganic mercury. Geneva: 1991
    Google Scholar
  • 61 Willhite CC, Karyakina NA, Yokel RA. et al. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol 2014; 44 Suppl 4 1-80
    Google Scholar
  • 62 Yassa HA. Autism: a form of lead and mercury toxicity. Environ Toxicol Pharmacol 2014; 38 (03) 1016-1024
    CrossrefGoogle Scholar